Over the last several years, it's become obvious thatpharmaceutical majors are willing to pay very substantialsums for access to promising research in genetics andgenomics. This not only includes major collaborationsbut also downright acquisitions. This week's issue ofBioWorld Financial Watch explores the trend. To order asubscription, call (800) 879-8790.

(c) 1997 American Health Consultants. All rights reserved.